Novedades

• US generics launch and approval for Dr Reddy’s and Lupin
• Five Chinese companies join UN’s MPP for Covid-19 medicines
• South Korean companies to make generic Bridion and COVID-19 drugs
• Revlimid (lenalidomide) generics launch across Europe

Investigación

• Trajectories of prices in generic drug markets
• Evaluation of pharmaceutical equivalency of manufactured generic drugs in UAE
• New insights into the amount of R & D for new uses of generic drugs
• Pricing and reimbursement of medicines in Canada

General

• Penetración de los medicamentos genéricos en México y Brasil
• FDA releases one-year progress report for the Generic Drug Cluster
• Empresas de fabricación de productos farmacéuticos en Brasil
• Empresas farmacéuticas en Argentina

Novedades

• EMA recommends approval of eculizumab biosimilar Epysqli
• New indication for Cosentyx (secukinumab) biological: hidradenitis suppurativa
• Advances for STADA-Xbrane’s Ximluci in Europe, the UK and the US
• Rinvoq approved to treat Crohn’s disease in Europe

Investigación

• High mannose glycans in biosimilars and their pharmacokinetic impact
• Biosimilars in Southern European Hospital Markets: barriers and determinants of uptake
• Using infliximab economic evaluations in IBD to inform biosimilar access policies
• Biosimilars and other copies of biological products

General

• Declaración conjunta sobre biosimilares en enfermedades inmunomediadas en España
• Biosimilars approved in the US
• Una actualización sobre la declaración conjunta EMA-HMA sobre la intercambiabilidad de biosimilares
• Biosimilars approved in Europe

• Latin American Forum
• Fármacos complejos no biológicos
• Enfoque por país

• Directrices
• Políticas y legislación
• Informes

• Congresos
• Artículos patrocinados
• Enlaces patrocinados